Ann Dermatol.  2018 Aug;30(4):475-478. 10.5021/ad.2018.30.4.475.

Clinical Efficacy of Oral Cyclosporine on Intractable Hand Eczema: A Retrospective Review of 16 Cases

• Kim HL
• Jung HJ
• Park MY
• Youn JI
• Ahn JY

• KMID: 2457529
• DOI: http://doi.org/10.5021/ad.2018.30.4.475

Abstract

No abstract available.

MeSH Terms

Cyclosporine*
Eczema*
Hand*
Retrospective Studies*
Treatment Outcome*
Cyclosporine

Figure

• 

  Fig. 1 Photographs taken at baseline (A, C) and at 4 weeks after treatments (B, D).

Reference

1. Lakshmi C, Srinivas CR. Hand eczema: an update. Indian J Dermatol Venereol Leprol. 2012; 78:569–582.

2. Johansen JD, Hald M, Andersen BL, Laurberg G, Danielsen A, Avnstorp C, et al. Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group. Contact Dermatitis. 2011; 65:13–21.

3. Diepgen TL, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, et al. Management of chronic hand eczema. Contact Dermatitis. 2007; 57:203–210.

4. Bissonnette R, Diepgen TL, Elsner P, English J, Graham-Brown R, Homey B, et al. Redefining treatment options in chronic hand eczema (CHE). J Eur Acad Dermatol Venereol. 2010; 24:Suppl 3. 1–20.

5. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996; 76:371–376.

6. Petersen CS, Menné T. Cyclosporin A responsive chronic severe vesicular hand eczema. Acta Derm Venereol. 1992; 72:436–437.

7. Granlund H, Erkko P, Reitamo S. Comparison of the influence of cyclosporine and topical betamethasone-17,21-dipropionate treatment on quality of life in chronic hand eczema. Acta Derm Venereol. 1997; 77:54–58.